Conflicting Triptan Data Leaves Clinicians Guessing

17 Oct 2026 0 comments

Two cohorts show no excess cardiovascular risk with triptans; two confounding-resistant studies show a two- to threefold rise. What it means for an old contraindication.
Medscape Medical News

Source: Medscape Neurology Published 16 Oct 2026 Imported 17 Oct 2026

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment